Consun Pharmaceutical Buys Back 406,000 Shares for HKD 5.27 Million
Consun Pharmaceutical repurchased 406,000 shares on the Hong Kong Stock Exchange on September 11, 2026, at prices between HKD 12.890 and HKD 13.060, for HKD 5.27 million. The stock closed at HKD 13.040, down 0.91%, with turnover of HKD 20.8835 million. The buyback marked the second consecutive trading day of repurchases, bringing the two-day total to 711,000 shares for HKD 9.2693 million.
Consun Pharmaceutical conducted a share buyback on the Hong Kong Stock Exchange on September 11, 2026, repurchasing 406,000 shares at prices ranging from HKD 12.890 to HKD 13.060, for a total of HKD 5.27 million. The stock closed that day at HKD 13.040, down 0.91% from the previous trading day, with full-day turnover of HKD 20.8835 million.
Since September 10, 2026, Consun Pharmaceutical has carried out buybacks on two consecutive trading days, repurchasing a combined 711,000 shares for a cumulative HKD 9.2693 million. Over this period, the stock price fell 0.84% in cumulative terms. From the start of 2026 through September 11, Consun Pharmaceutical completed 22 share buybacks in total, repurchasing 3.309 million shares for a cumulative HKD 44.7251 million.
According to disclosed buyback details, on January 6, 2026, Consun Pharmaceutical repurchased 100,000 shares at prices ranging from HKD 15.500 to HKD 15.510, for HKD 1.5505 million. Between May 20 and May 28, 2026, the company conducted four buybacks, repurchasing a combined 459,000 shares at prices ranging from HKD 13.880 to HKD 14.490. Between June 2 and June 30, 2026, the company conducted 15 buybacks, repurchasing a combined 2.04 million shares at prices ranging from HKD 12.480 to HKD 14.390. On September 10, 2026, the company repurchased 305,000 shares at prices ranging from HKD 12.870 to HKD 13.160, for HKD 3.9994 million.